A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Clinical trial NCT03309358 · TERMINATED

Trial details

NCT number: NCT03309358
Sponsor: Synspira, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Diseases Pulmonary Disease Cystic Fibrosis Cystic Fibrosis Lung Cystic Fibrosis Pulmonary Exacerbation Cystic Fibrosis With Exacerbation Respiratory Tract Disease Pulmonary Inflammation Multi-antibiotic Resistance Antibiotic Resistant Infection Lung Infection Lung Infection Pseudomonal

Start date: 2017-09-28
Primary completion: 2017-12-18
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.